Press Release
Novel test supports vaccine development studies critical to aiding researchers in understanding immunity levels and disease progression
EUROIMMUN, a PerkinElmer company, today announced that is has launched a SARS-CoV-2 Interferon Gamma Release Assay (IGRA) for Research Use Only (RUO) to determine the activity of T-cells reactive to SARS-CoV-2, the pathogen causing COVID-19.
Read complete press release here.
